Experience what ATE has to offer...
2025 Event Highlights
500
Attendees (Max Capacity reached)
35+
Countries Represented
110+
Speakers
170+
Therapeutic Developers & Pharma
Curated. Connected. Designed for impact.
Entering its 6th year, Advanced Therapies Europe 2026 remains an intentionally intimate gathering of senior decision-makers, designed to ensure every conversation delivers real impact. Returning to Barcelona in 2026, the centre of Europe’s dynamic and fast-growing biotech ecosystem, where strategic connections spark progress and insights translate into action. Whether your goal is to invest, scale, partner, or launch, Advanced Therapies Europe 2026 is the platform to make it happen.
Who is Advanced Therapies Europe for?
Advanced Therapies Europe is a focused conference and networking event for the advanced therapies and regenerative medicine community. It brings together key people across European biotech and life sciences to discuss innovation, investment and bringing new treatments to market.
The event will take place in Barcelona, Spain 2026.
If you work in cell and gene therapy, regenerative medicine, biotech investment or manufacturing, this event is designed for you. It is ideal for senior leaders, scientists, investors, regulators and solution providers involved in the future of advanced therapies in Europe.
Yes. The event is a great opportunity for early-stage companies to meet potential partners, investors and industry experts in a more personal and focused setting.
Unlike larger exhibitions, this event focuses on in-depth discussion, targeted networking and knowledge sharing. It is smaller and more selective, with around 500 senior attendees, designed to encourage meaningful conversations and connections.
Sessions explore a wide range of issues across the advanced therapies field, including clinical development, commercial strategy, regulatory planning, manufacturing, market access and patient involvement.
Yes. The event includes a one-to-one partnering system so you can arrange meetings with potential collaborators, investors or clients before and during the event.
Yes. The event is built to help you meet deal makers, funders and biotech leaders from across the sector. It is a valuable chance to connect with people who influence the direction of advanced therapies in Europe.
Registration is currently not live for 2026, but you can register your interest to be among the first to be notified.
Download the 2025 sample attendee list
)
)
)
)
)
)
)
)
)
)
Advanced Therapies Europe Media
-
)
Aleck Jones, CEO and Co-Founder of Kindling Bio and winner of the Advanced Therapies Europe 2025 Inn ... -
)
Despite the gloom, the data say otherwise: record UK raises and a string of $100M+ “mega deals” acro ... -
)
Former Okon Therapeutics CEO Keren Leshem lays out how a contraceptive “ball” IUD became a uterine d ... -
)
The room was full, the stats were sobering, and the advice was refreshingly actionable. Leaders from ... -
)
This workshop laid out how biology, platforms, and policy can move genomic medicines from promising ... -
)
Late-stage AAV success is less about bigger bioreactors and more about decisions that lock in supply ... -
)
The panel agrees the future is decentralized, hybrid, and data driven. Inline analytics, digital bat ... -
)
The UK punches above its weight in advanced therapies: a dense concentration of developers, a single ... -
)
Cell and gene therapies live or die on logistics. Time, temperature, and traceability must survive e ... -
)
The Nordic ecosystem leads in discovery and process innovation, supported by a public that embraces ... -
)
Mayra Battilani Becegato, former EMEA Commercial Strategy Director for Gene Therapy – Rare Diseases ... -
)
Barcelona is a thriving strategic hub for advanced therapies. At Advanced Therapies Europe 2025, the ... -
)
Get an exclusive first look at what’s in store for Advanced Therapies Europe 2025. This live webinar ... -
)
Marion Hitchcock, Managing Director of the Gene & Cell Therapies Incubator Berlin and R&D Strategy & ...